GB1413008A - Quinazolin-sulphonamide potassium salts - Google Patents
Quinazolin-sulphonamide potassium saltsInfo
- Publication number
- GB1413008A GB1413008A GB2165173A GB2165173A GB1413008A GB 1413008 A GB1413008 A GB 1413008A GB 2165173 A GB2165173 A GB 2165173A GB 2165173 A GB2165173 A GB 2165173A GB 1413008 A GB1413008 A GB 1413008A
- Authority
- GB
- United Kingdom
- Prior art keywords
- potassium salts
- quinazolin
- atom
- replaced
- sulphamoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Quinazolin-sulphonamide potassium salts Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229910052700 potassium Inorganic materials 0.000 abstract 2
- PKORYTIUMAOPED-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinazoline Chemical group C1=CC=C2NCNCC2=C1 PKORYTIUMAOPED-UHFFFAOYSA-N 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- DBDTUXMDTSTPQZ-UHFFFAOYSA-N fenquizone Chemical class N1C=2C=C(Cl)C(S(=O)(=O)N)=CC=2C(=O)NC1C1=CC=CC=C1 DBDTUXMDTSTPQZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 159000000001 potassium salts Chemical class 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2392572 | 1972-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1413008A true GB1413008A (en) | 1975-11-05 |
Family
ID=11210914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2165173A Expired GB1413008A (en) | 1972-05-05 | 1973-05-07 | Quinazolin-sulphonamide potassium salts |
Country Status (12)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE502635T1 (de) | 2002-08-19 | 2011-04-15 | Pfizer | Kombinationstherapie gegen hyperproliferative erkrankungen |
| US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| JP5498168B2 (ja) | 2006-12-01 | 2014-05-21 | ブリストル−マイヤーズ スクイブ カンパニー | アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体 |
| JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| MA54261B1 (fr) | 2019-01-18 | 2025-03-28 | Astrazeneca Ab | Inhibiteurs de pcsk9 et leurs procédés d'utilisation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2952680A (en) * | 1960-09-13 | Derivatives of x-quevazolone | ||
| US987847A (en) * | 1910-04-12 | 1911-03-28 | Rubin W Weeks | Harness. |
| US3440244A (en) * | 1958-02-17 | 1969-04-22 | Pfizer & Co C | 3,6-disubstituted-7-sulfamyl-1,2,4-benzthiazide-1,1-dioxides |
| US3072656A (en) * | 1960-01-22 | 1963-01-08 | Ciba Geigy Corp | 2-cycloaliphatic-6-sulfamyl-7-halo(or trihalomethyl)-1, 2, 3, 4-tetrahydro-4-quinazolones |
| US3360518A (en) * | 1966-01-03 | 1967-12-26 | Wallace & Tiernan Inc | Tetrahydro-halo-sulfamyl quinazolinones |
-
1973
- 1973-05-01 ZA ZA732937A patent/ZA732937B/xx unknown
- 1973-05-02 US US356403A patent/US3870720A/en not_active Expired - Lifetime
- 1973-05-03 NL NL7306164A patent/NL7306164A/xx unknown
- 1973-05-03 JP JP48049593A patent/JPS49132221A/ja active Pending
- 1973-05-03 AU AU55161/73A patent/AU469087B2/en not_active Expired
- 1973-05-04 BE BE130734A patent/BE799087A/xx unknown
- 1973-05-04 SE SE7306244A patent/SE400768B/xx unknown
- 1973-05-04 CA CA171,105A patent/CA982578A/en not_active Expired
- 1973-05-04 FR FR7316142A patent/FR2183806B1/fr not_active Expired
- 1973-05-04 DK DK247673AA patent/DK131033B/da not_active IP Right Cessation
- 1973-05-05 DE DE2322699A patent/DE2322699C2/de not_active Expired
- 1973-05-07 GB GB2165173A patent/GB1413008A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK131033B (da) | 1975-05-20 |
| DE2322699C2 (de) | 1983-10-27 |
| AU5516173A (en) | 1974-11-07 |
| DE2322699A1 (de) | 1974-01-10 |
| FR2183806B1 (enrdf_load_html_response) | 1976-05-14 |
| SE400768B (sv) | 1978-04-10 |
| JPS49132221A (enrdf_load_html_response) | 1974-12-18 |
| NL7306164A (enrdf_load_html_response) | 1973-11-07 |
| ZA732937B (en) | 1974-03-27 |
| FR2183806A1 (enrdf_load_html_response) | 1973-12-21 |
| US3870720A (en) | 1975-03-11 |
| CA982578A (en) | 1976-01-27 |
| AU469087B2 (en) | 1976-02-05 |
| BE799087A (fr) | 1973-08-31 |
| DK131033C (enrdf_load_html_response) | 1975-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1383784A (en) | Zoom lens | |
| GB1429926A (en) | Benzothiadiazoles | |
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| GB1413008A (en) | Quinazolin-sulphonamide potassium salts | |
| FR2234221B1 (enrdf_load_html_response) | ||
| GB1466932A (en) | 11-h-pyrimido-4,5-b- 1,4,-benzodiazepines | |
| GB1449404A (en) | N-arylsulphonyl urea derivatives | |
| GB1363047A (en) | Pyrimidine derivative process for its preparation and its use as a medicament | |
| GB1331161A (en) | Amino-s-triazolylbenzenesulphonamides | |
| NL7411531A (nl) | Koolzuurderivaten van 2-mercapto 4.5-dichloor- thiazolen, alsmede werkwijze voor de bereiding en toepassing ervan als herbiciden. | |
| NL184619C (nl) | Werkwijze ter bereiding van anti-bacterieel werkzame farmaceutische preparaten alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte 5-benzyl-2,4-diaminopyrimidinederivaten. | |
| CA972288A (en) | Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity | |
| GB1429808A (en) | Polypeptides having acth activity | |
| GB1435685A (en) | Hydroxyl-subst | |
| IE34590L (en) | Phenylethanolamine derivatives | |
| GB1136918A (en) | Propanolamine derivatives | |
| GB1296333A (enrdf_load_html_response) | ||
| GB1420777A (en) | Coumarin and coumarinimide compounds | |
| GB1363986A (en) | Diphenylmethoxyethylamines | |
| GB1377787A (en) | Aminopropanol derivatives | |
| GB1317099A (en) | 3-sulphamyl-4-chlorobenzoic acid derivatives | |
| GB1461860A (en) | Semi-synthetic penicillin | |
| GB1342643A (en) | Thioacetanilide derivatives | |
| GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
| GB1368487A (en) | /pyrazolo/3,4-b/pyridin-5-yl-form-amidoethyl//phenyl-su lphonylureas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |